Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc RDDTF


Primary Symbol: V.RTI.H

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Comment by bbuddwisserr104on Dec 25, 2020 8:34am
150 Views
Post# 32182406

RE:RE:radient

RE:RE:radient
lscfa wrote:

Canopy will lose. Supercritical Fluid Extraction has been around since the mid-1980s, well before the 2000 patent. Canopy paid $1.00 for the patent. What does that tell you?   

For GW Pharmaceuticals to win, the company will have to demonstrate that its method, described in broad terms on its website, uses technology not claimed in Canopy’s patent—or that the technology that Canopy’s new patent claims were “known or obvious” in 2000, when the patent application was filed.  They bought the patent from a company they owned in germany  for a buck what does that tell you


 

bbuddwisserr104 wrote: is getting help from canopy  this should drive some other companies over to maps extraction with canopy sueing gw pharma over the use of co2 extraction which they have a patent as of today in the usa the patent expire in 1 1/2 years they got this co2 patent when they bought c3 cannabiboid in germany for 250m in 2019  valens   medipharm boss etc are in trouble i would think  how much is it going to cost to get a lic from cgc

 

 



<< Previous
Bullboard Posts
Next >>